PAF promotes stemness and radioresistance of glioma stem cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 43, 2017, Pages E9085-E9095

  Ong, Derrick Sek Tong ^a,b,c   Hu, Baoli ^a,d,e   Ho, Yan Wing ^a   Sauvé, Charles Etienne Gabriel ^a   Bristow, Christopher A ^a   Wang, Qianghu ^a   Multani, Asha S ^a   Chen, Peiwen ^a   Nezi, Luigi ^a   Jiang, Shan ^a   Gorman, Claire Elizabeth ^a   Monasterio, Marta Moreno ^a   Koul, Dimpy ^a   Marchesini, Matteo ^a   Colla, Simona ^a   Jin, Eun Jung ^f   Sulman, Erik P ^a   Spring, Denise J ^a   Yung, Wai Kwan Alfred ^a   Verhaak, Roel G W ^g   Chin, Lynda ^a   Wang, Y Alan ^a   DePinho, Ronald A ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f Wonkwang University   (South Korea)

^g JACKSON LABORATORY   (United States)

Author keywords

DNA translesion synthesis; Glioma stem cells; Self renewal

Indexed keywords

ACTIN; BLOOM SYNDROME HELICASE; CD133 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROLIFERATING CELL NUCLEAR ANTIGEN ASSOCIATED FACTOR; PROTEIN; RPA2 PROTEIN; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SOX2; TUJ 1 PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; GREEN FLUORESCENT PROTEIN; KIAA0101 PROTEIN, HUMAN; PYRIMIDINE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENICITY; CELL DIFFERENTIATION; CHROMOSOME ABERRATION; DNA REPLICATION; FEMALE; GLIOBLASTOMA; GLIOMA; GLIOMA STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLOMICS; MOUSE; NEURAL STEM CELL; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIMIDINE METABOLISM; RADIOSENSITIVITY; STEM CELL SELF-RENEWAL; TRANSCRIPTOMICS; ANIMAL; BIOSYNTHESIS; BRAIN TUMOR; CANCER STEM CELL; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PATHOLOGY; RADIATION RESPONSE; RADIATION TOLERANCE; SCID MOUSE;

ANIMALS; BRAIN NEOPLASMS; CARRIER PROTEINS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GREEN FLUORESCENT PROTEINS; HUMANS; MICE, SCID; NEOPLASTIC STEM CELLS; PYRIMIDINES; RADIATION TOLERANCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85032200761     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1708122114     Document Type: Article

References (46)

1. Huse JT, Holland EC (2010) Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10:319-331.
2. Lathia JD, et al. (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6:421-432.
3. Li Z, et al. (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15:501-513.
4. Singh SK, et al. (2004) Identification of human brain tumour initiating cells. Nature 432:396-401.
5. Gaiano N, Fishell G (2002) The role of notch in promoting glial and neural stem cell fates. Annu Rev Neurosci 25:471-490.
6. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A (2007) HEDGEHOG- GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17:165-172.
7. Ligon KL, et al. (2007) Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53:503-517.
8. Hemmati HD, et al. (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100:15178-15183.
9. Tunici P, et al. (2004) Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Mol Cancer 3:25.
10. Bao S, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760.
11. Singh SK, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828.
12. Son MJ, Woolard K, Nam DH, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440-452.
13. Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CLL, Rich JN (2015) Cancer stem cells in glioblastoma. Genes Dev 29:1203-1217.
14. Chen J, et al. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522-526.
15. Kayaselçuk F, Zorludemir S, Gümürdühü D, Zeren H, Erman T (2002) PCNA and Ki-67 in central nervous system tumors: Correlation with the histological type and grade. J Neurooncol 57:115-121.
16. Bartkova J, et al. (2010) Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas. Oncogene 29:5095-5102.
17. Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481:287-294.
18. Carruthers R, et al. (2015) Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase. Mol Oncol 9:192-203.
19. Ahmed SU, et al. (2015) Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells. Cancer Res 75: 4416-4428.
20. Venere M, et al. (2014) Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells. Cell Death Differ 21:258-269.
21. Ghosal G, Chen J (2013) DNA damage tolerance: A double-edged sword guarding the genome. Transl Cancer Res 2:107-129.
22. Ferrón S, et al. (2004) Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells. Development 131: 4059-4070.
23. Jaskelioff M, et al. (2011) Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469:102-106.
24. Wong KK, et al. (2000) Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 26:85-88.
25. De Biasio A, et al. (2015) Structure of p15(PAF)-PCNA complex and implications for clamp sliding during DNA replication and repair. Nat Commun 6:6439.
26. Wu L (2007) Role of the BLM helicase in replication fork management. DNA Repair (Amst) 6:936-944.
27. Davies AA, Huttner D, Daigaku Y, Chen S, Ulrich HD (2008) Activation of ubiquitindependent DNA damage bypass is mediated by replication protein a. Mol Cell 29: 625-636.
28. Huang TT, et al. (2006) Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol 8:339-347.
29. Hu B, et al. (2016) Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell 167:1281-1295.e18.
30. Chang CN, Feng MJ, Chen YL, Yuan RH, Jeng YM (2013) p15(PAF) is an Rb/E2Fregulated S-phase protein essential for DNA synthesis and cell cycle progression. PLoS One 8:e61196.
31. Emanuele MJ, Ciccia A, Elia AEH, Elledge SJ (2011) Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphasepromoting complex/cyclosome substrate. Proc Natl Acad Sci USA 108:9845-9850.
32. Povlsen LK, et al. (2012) Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol 14:1089-1098.
33. Jung HY, et al. (2013) PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation. Mol Cell 52:193-205.
34. Wang X, et al. (2016) PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun 7:10633.
35. Jun S, et al. (2013) PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. Cell Rep 5:314-322.
36. Wang X, et al. (2017) Purine synthesis promotes maintenance of brain tumor initiating cells in glioma. Nat Neurosci 20:661-673.
37. Diamant N, et al. (2012) DNA damage bypass operates in the S and G2 phases of the cell cycle and exhibits differential mutagenicity. Nucleic Acids Res 40:170-180.
38. Cotto-Rios XM, Jones MJK, Busino L, Pagano M, Huang TT (2011) APC/CCdh1- dependent proteolysis of USP1 regulates the response to UV-mediated DNA damage. J Cell Biol 194:177-186.
39. Inoue A, et al. (2014) A small molecule inhibitor of monoubiquitinated proliferating cell nuclear antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin. J Biol Chem 289: 7109-7120.
40. Liang Q, et al. (2014) A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat Chem Biol 10:298-304.
41. Godek KM, et al. (2016) Chromosomal instability affects the tumorigenicity of glioblastoma tumor-initiating cells. Cancer Discov 6:532-545.
42. Amrani YM, et al. (2011) The Paf oncogene is essential for hematopoietic stem cell function and development. J Exp Med 208:1757-1765.
43. National Research Council (2011) Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, DC), 8th Ed.
44. Lal S, et al. (2000) An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg 92:326-333.
45. Ziv O, et al. (2014) Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin. Nat Commun 5:5437.
46. Yuan M, Breitkopf SB, Yang X, Asara JM (2012) A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 7:872-881.